Baum MS - Search Results

1

Capecitabine-induced coronary vasospasm.

Goldsmith YB, Roistacher N, Baum MS. Goldsmith YB, et al. Among authors: baum ms. J Clin Oncol. 2008 Aug 1;26(22):3802-4. doi: 10.1200/JCO.2008.17.1637. J Clin Oncol. 2008. PMID: 18669470 No abstract available.

2

Cardiac metastases from head and neck cancer mimicking a myocardial infarction.

Yadav NU, Gupta D, Baum MS, Roistacher N, Steingart RM. Yadav NU, et al. Among authors: baum ms. J Oral Maxillofac Surg. 2014 Aug;72(8):1627-35. doi: 10.1016/j.joms.2014.02.015. Epub 2014 Feb 15. J Oral Maxillofac Surg. 2014. PMID: 24813774

3

Signal-averaged P-wave duration does not predict atrial fibrillation after thoracic surgery.

Amar D, Roistacher N, Zhang H, Baum MS, Ginsburg I, Steinberg JS. Amar D, et al. Among authors: baum ms. Anesthesiology. 1999 Jul;91(1):16-23. doi: 10.1097/00000542-199907000-00007. Anesthesiology. 1999. PMID: 10422924 Free article.

4

Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.

Feldman DR, Baum MS, Ginsberg MS, Hassoun H, Flombaum CD, Velasco S, Fischer P, Ronnen E, Ishill N, Patil S, Motzer RJ. Feldman DR, et al. Among authors: baum ms. J Clin Oncol. 2009 Mar 20;27(9):1432-9. doi: 10.1200/JCO.2008.19.0108. Epub 2009 Feb 17. J Clin Oncol. 2009. PMID: 19224847 Free PMC article. Clinical Trial.

5

Phase I/II trial of sunitinib plus gefitinib in patients with metastatic renal cell carcinoma.

Motzer RJ, Hudes GR, Ginsberg MS, Baum MS, Harmon CS, Kim ST, Chen I, Redman BG. Motzer RJ, et al. Among authors: baum ms. Am J Clin Oncol. 2010 Dec;33(6):614-8. doi: 10.1097/COC.0b013e3181c4454d. Am J Clin Oncol. 2010. PMID: 20142724 Clinical Trial.

6

Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes.

Klimek VM, Fircanis S, Maslak P, Guernah I, Baum M, Wu N, Panageas K, Wright JJ, Pandolfi PP, Nimer SD. Klimek VM, et al. Clin Cancer Res. 2008 Feb 1;14(3):826-32. doi: 10.1158/1078-0432.CCR-07-0318. Clin Cancer Res. 2008. PMID: 18245545 Clinical Trial.

7

Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma.

Molina AM, Feldman DR, Voss MH, Ginsberg MS, Baum MS, Brocks DR, Fischer PM, Trinos MJ, Patil S, Motzer RJ. Molina AM, et al. Among authors: baum ms. Cancer. 2012 Apr 1;118(7):1868-76. doi: 10.1002/cncr.26429. Epub 2011 Sep 6. Cancer. 2012. PMID: 21898375 Free PMC article. Clinical Trial.

8

Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma.

Molina AM, Feldman DR, Ginsberg MS, Kroog G, Tickoo SK, Jia X, Georges M, Patil S, Baum MS, Reuter VE, Motzer RJ. Molina AM, et al. Among authors: baum ms. Invest New Drugs. 2012 Feb;30(1):335-40. doi: 10.1007/s10637-010-9491-6. Epub 2010 Aug 14. Invest New Drugs. 2012. PMID: 20711632 Free PMC article. Clinical Trial.

9

Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial.

Rini BI, Quinn DI, Baum M, Wood LS, Tarazi J, Rosbrook B, Arruda LS, Cisar L, Roberts WG, Kim S, Motzer RJ. Rini BI, et al. Target Oncol. 2015 Mar;10(1):45-53. doi: 10.1007/s11523-014-0307-z. Epub 2014 Mar 5. Target Oncol. 2015. PMID: 24595903 Free PMC article. Clinical Trial.

10

Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.

Rini BI, Cohen DP, Lu DR, Chen I, Hariharan S, Gore ME, Figlin RA, Baum MS, Motzer RJ. Rini BI, et al. Among authors: baum ms. J Natl Cancer Inst. 2011 May 4;103(9):763-73. doi: 10.1093/jnci/djr128. Epub 2011 Apr 28. J Natl Cancer Inst. 2011. PMID: 21527770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page